Global 3D Bioprinting Market Research Report and Forecast 2022-2027
© 2019 IMARC All Rights Reserved
Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group
About IMARC Group
Report Description
The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights
Report Description
Global 3D Bioprinting Market Outlook 2026: The latest report by IMARC Group, titled “ 3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-202 6 ,” finds that the global 3D bioprinting market reached a value of US$ 933.9 Million in 2021. 3D bioprinting refers to the medical application of 3D printers for fabricating biological tissues and organs through the layering of living cells. It creates spatially-controlled patterns in 3D where viability and cell function are conserved within the printed construct. 3D bioprinting utilizes a layer-by-layer method to deposit materials like bio-inks. Bio-inks are obtained from living cells, biomaterials, and active biomolecules to create the 3D structure of tissues and organs. The technology offers speedy and accurate drug testing as potential drug compounds can be tested on bio-printed tissue before being used in human trials. It is also used to build complex bodily structures, including bones, skin, vascular grafts, tracheal splints, heart tissues, and cartilages. As a result, 3D bioprinting finds applications in the research and development of drugs, scaffolds, and medical implants. Request for a free sample: https://www.imarcgroup.com/3d-bioprinting-market/requestsample
Report Description and Highlights
Report Description
Global 3D Bioprinting Market Trends: The market is primarily driven by the increasing geriatric population and rising instances of respiratory and cardiovascular diseases that require organ transplants. The limited number of organ donors is propelling the demand for 3D bioprinting across healthcare organizations. In addition to this, the technology is used in cosmetic surgeries and the pharmaceutical industry, further supplementing the market growth. This has also resulted in growing public and private fundings, which have prompted market players to improve and strengthen their manufacturing and distribution capabilities. As a result, 3D bioprinting is used to create simple tissue structures in a lab setting; however, it can also build complete organs for transplants in the future, owing to technological advancements and the manufacturing of customized products. Moreover, manufacturers have introduced organ-on-a-chip and bio-printed structures that enable a 3D in-vitro analysis of bodily functions and aids in developing artificial organs and tissues. Furthermore, extensive R&D investments and increasing stem cell research have increased awareness regarding 3D bioprinting, which is positively influencing the market growth.
Report Description and Highlights Report Description Market Summary: Breakup by Component: • Syringe/Extrusion Bioprinting • Inkjet Bioprinting • Magnetic Levitation Bioprinting • Laser-assisted Bioprinting • Living Cells • Hydrogels • Extracellular Matrices Breakup by Application: • Research • Drug Research • Regenerative Medicine • 3D Cell Culture • Clinical • Skin • Bone and Cartilage • Blood Vessels
Report Description and Highlights Report Description Breakup by End User: • Hospitals • Research Organization and Academic Institutes • Biopharmaceuticals Companies Breakup by Region: • North America • Asia Pacific • Europe • Middle East and Africa • Latin America Looking forward, the market value is expected to grow at US$ 2,706.0 Million by 2027, exhibiting a CAGR of 19.4% during the forecast period (2022-2027).
Report Description and Highlights Report Description Competitive Landscape With Key players: • 3D Systems Inc • Aspect Biosystems Ltd • Cellink • Cyfuse Biomedical K.K • EnvisionTEC GmbH (Desktop Metal Inc.) • GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH • Materialise • Organovo Holdings Inc • Poietis • RegenHU • Stratasys Ltd • 3D Systems Inc • Aspect Biosystems Ltd View Report TOC, Figures and Tables: https://www.imarcgroup.com/3d-bioprinting-/requestsample
A partial List of
We are the trusted business partners to the
Clients world's leading corporates, governments, and ourPartial ClientsList of institutions
A partial List of
We are the trusted business partners to the
of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions
Report Description and Highlights
Report Description
© 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
https://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com